Songül KARACAM, Ismet ŞAHINLER, Gülyüz ATKOVAR, Şefika Arzu ERGEN, Olgun ELICIN, Servet IPEK

3424

Dosimetric Comparison of Static Field Intensity-Modulated Radiotherapy and Volumetric Modulated Arc Therapy for Adjuvant Treatment of Patients with Endometrial Cancer

Dosimetric Comparison of Static Field Intensity-Modulated Radiotherapy and Volumetric Modulated Arc Therapy for Adjuvant Treatment of Patients with Endometrial Cancer

OBJECTIVE The extent of previously published studies comparing static intensity-modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) in the adjuvant setting of endometrial cancer is limited and reports do not cover the whole landscape of today’s clinical practice. The aim of this study was to compare these treatment techniques. METHODS Using 12 image sets, VMAT with double arcs and IMRT with 7 fields were planned. The femoral heads, rectum, bladder, iliac bone marrow, and bowels were contoured as organs at risk (OARs). Planned treatment volume (PTV) was prescribed to be 45 gray (Gy). Target and OAR parameters, conformity, and homogeneity indices were evaluated. P value under 0.05 was considered statistically significant. RESULTS Objectives for target volumes were achieved. No significant differences were found in conformity index, maximum dose (Dmax), or integral dose. Homogeneity index was better with IMRT (1.06 vs. 1.07; p< 0.01). Dose received by 2% volume of PTV (D2%), D5%, the volume receiving 107% of prescribed dose (V107%), and V105% were lower with IMRT (p< 0.05). PTV D98%, percent volume receiving ≥45 Gy (V45 Gy), and clinical target volume V45 Gy were higher with VMAT (p< 0.05). Regarding OARs, only rectum V40 Gy, rectum PTV V40 Gy, and dose volume parameter D2cc were lower with VMAT (p< 0.05). VMAT was superior with respect to monitor units and beam-on time per fraction: 465 vs. 1689 and 166 vs. 338 seconds, respectively (p< 0.001). CONCLUSION Static IMRT is superior to VMAT regarding homogeneity, Dmax and OAR sparing, except for the rectum and the bladder. However, it is a marginal benefit with small differences. VMAT remains an attractive solution due to low number of monitor units needed and shorter treatment duration, which allows more time for patient imaging and positioning.
PDF

___

  • 1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61(2):69–90.
  • 2. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER Cancer Statistics Review, 1975-2007. National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975_2007/. Accessed Jun 14, 2017.
  • 3. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Uterine Neoplasms Version 2. 2015. Available at: http://www.nccn.org/professionals/ physician_gls/pdf/uterine.pdf. Accessed Jun 14, 2017.
  • 4. Gay HA, Barthold HJ, O’Meara E, Bosch WR, El Naqa I, Al-Lozi R, et al. Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas. Int J Radiat Oncol Biol Phys 2012;83(3):e353–62.
  • 5. Small W, Mundt AJ. Consensus guidelines for the delineation of the intensity modulated pelvic radiotherapy ctv in the postoperative treatment of endometrial and cervical cancer. Available at: http://www.rtog.org/ CoreLab/ContouringAtlases/GYN.aspx. Accessed Jun 14, 2017.
  • 6. Gay HA, Barthold J, O’Meara E, Bosch WR, El Naqa I, Al-Lozi R, et al. Female RTOG Normal Pelvis Atlas. Available at: https://www.rtog.org/CoreLab/ContouringAtlases/FemaleRTOGNormalPelvisAtlas.aspx. Accessed Jun 14, 2017.
  • 7. Mundt AJ, Lujan AE, Rotmensch J, Waggoner SE, Yamada SD, Fleming G, et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2002;52(5):1330–7.
  • 8. Lujan AE, Mundt AJ, Yamada SD, Rotmensch J, Roeske JC. Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy. Int J Radiat Oncol Biol Phys 2003;57(2):516–21.
  • 9. Mundt AJ, Mell LK, Roeske JC. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys 2003;56(5):1354–60.
  • 10.Jhingran A, Winter K, Portelance L, Miller B, Salehpour M, Gaur R, et al. A phase II study of intensity modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: radiation therapy oncology group trial 0418. Int J Radiat Oncol Biol Phys 2012;84(1):e23–8.
  • 11.Wong E, D’Souza DP, Chen JZ, Lock M, Rodrigues G, Coad T, et al. Intensity-modulated arc therapy for treatment of high-risk endometrial malignancies. Int J Radiat Oncol Biol Phys 2005;61(3):830–41.
  • 12.Cozzi L, Dinshaw KA, Shrivastava SK, Mahantshetty U, Engineer R, Deshpande DD, et al. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol 2008;89(2):180–91.
  • 13.Bragg CM, Wingate K, Conway J. Clinical implications of the anisotropic analytical algorithm for IMRT treatment planning and verification. Radiother Oncol 2008;86(2):276–84.
  • 14.Fogliata A, Vanetti E, Albers D, Brink C, Clivio A, Knöös T, et al. On the dosimetric behaviour of photon dose calculation algorithms in the presence of simple geometric heterogeneities: comparison with Monte Carlo calculations. Phys Med Biol 2007;52(5):1363–85.
  • 15.Knöös T, Wieslander E, Cozzi L, Brink C, Fogliata A, Albers D, et al. Comparison of dose calculation algorithms for treatment planning in external photon beam therapy for clinical situations. Phys Med Biol 2006;51(22):5785–807.
  • 16.Feuvret L, Noël G, Mazeron JJ, Bey P. Conformity index: a review. Int J Radiat Oncol Biol Phys 2006;64(2):333–42.
  • 17.Roeske JC, Lujan A, Rotmensch J, Waggoner SE, Yamada D, Mundt AJ. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2000;48(5):1613– 21.
  • 18.Ahamad A, D’Souza W, Salehpour M, Iyer R, Tucker SL, Jhingran A, et al. Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissuesparing effect to margin size. Int J Radiat Oncol Biol Phys 2005;62(4):1117–24.
  • 19.Georg P, Georg D, Hillbrand M, Kirisits C, Pötter R. Factors influencing bowel sparing in intensity modulated whole pelvic radiotherapy for gynaecological malignancies. Radiother Oncol 2006;80(1):19–26.
  • 20.Iğdem S, Ercan T, Alço G, Zengin F, Ozgüleş R, Geceer G, et al. Dosimetric comparison of intensity modulated pelvic radiotherapy with 3D conformal radiotherapy in patients with gynecologic malignancies. Eur J Gynaecol Oncol 2009;30(5):547–51.
  • 21.Yang B, Zhu L, Cheng H, Li Q, Zhang Y, Zhao Y. Dosimetric comparison of intensity modulated radiotherapy and three-dimensional conformal radiotherapy in patients with gynecologic malignancies: a systematic review and meta-analysis. Radiat Oncol 2012;7:197.
  • 22.Yang R, Jiang W, Wang J. A novel conformal arc technique for postoperative whole pelvic radiotherapy for endometrial cancer. Int J Gynecol Cancer 2009;19(9):1574–9.
  • 23. Sharfo AW, Voet PW, Breedveld S, Mens JW, Hoogeman MS, Heijmen BJ. Comparison of VMAT and IMRT strategies for cervical cancer patients using automated planning. Radiother Oncol 2015;114(3):395–401.
  • 24.Lian J, Mackenzie M, Joseph K, Pervez N, Dundas G, Urtasun R, et al. Assessment of extended-field radiotherapy for stage IIIC endometrial cancer using three-dimensional conformal radiotherapy, intensitymodulated radiotherapy, and helical tomotherapy. Int J Radiat Oncol Biol Phys 2008;70(3):935–43.
  • 25.Yang R, Xu S, Jiang W, Xie C, Wang J. Integral dose in three-dimensional conformal radiotherapy, intensitymodulated radiotherapy and helical tomotherapy. Clin Oncol (R Coll Radiol) 2009;21(9):706–12.
  • 26.Alaei P, Spezi E. Imaging dose from cone beam computed tomography in radiation therapy. Phys Med 2015;31(7):647–58.
  • 27.Jhingran A, Salehpour M, Sam M, Levy L, Eifel PJ. Vaginal motion and bladder and rectal volumes during pelvic intensity-modulated radiation therapy after hysterectomy. Int J Radiat Oncol Biol Phys 2012;82(1):256–62.
Türk Onkoloji Dergisi-Cover
  • ISSN: 1300-7467
  • Başlangıç: 2015
  • Yayıncı: Ali Cangül
Arşiv
Sayıdaki Diğer Makaleler

Cancer Incidence 2010-2014 Among the North Cyprus Population of Adults Aged 15 and Over

Evren HINÇAL, Deniz GRANIT, Nuriye SANCAR, Meltem NALÇA ANDRIEU

Challenges Experienced by and Quality of Life of Relatives of Cancer Patients Requiring Palliative Care at Home

Medine YILMAZ, Cihan GÜLTAŞ

Dosimetric Comparison of Static Field Intensity-Modulated Radiotherapy and Volumetric Modulated Arc Therapy for Adjuvant Treatment of Patients with Endometrial Cancer

Songül KARACAM, Ismet ŞAHINLER, Gülyüz ATKOVAR, Şefika Arzu ERGEN, Olgun ELICIN, Servet IPEK

Effects of Image-Guided Adaptive Brachytherapy on Morbidity and Quality of Life in Cervical Cancer

Ayşe Nur DEMİRAL

Volumetric Arc Therapy Seems More Promising for Sparing Organs at Risk in Adjuvant Postoperative Radiotherapy for Pancreatic Adenocarcinoma than Step-and-Shoot Intensity-Modulated Radiotherapy

Uğur SELEK, Duygu SEZEN, Yasemin BÖLÜKBAŞI, Yücel SAĞLAM, Z. Vildan ALPAN, Steve KIRSNER